Description
| Product Name | Details | CAT.No | Size |
| CO2 | Suitable for Hitachi 917 | HIT0152C | R1: 6 x 20ml |
| CO2 Monoliquid | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0152C | R1: 4 x 20ml |
| CO2 Total | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF152A | R1:4 x 21.7ml |
Product Description
The Biorex Diagnostics CO₂ Assay is an in vitro diagnostic test designed for the quantitative determination of total carbon dioxide in human serum and plasma. Total CO₂ primarily reflects bicarbonate levels, a crucial component in maintaining acid–base balance, and provides vital insights into respiratory function, metabolic processes, and overall systemic homeostasis. Accurate assessment of total CO₂ is essential for identifying and monitoring disturbances such as metabolic or respiratory acidosis and alkalosis, which can have significant clinical implications if left unrecognized.
By measuring total CO₂, clinicians can evaluate the patient’s acid–base status, monitor electrolyte balance, and detect early signs of metabolic derangements. The Biorex CO₂ Assay is particularly useful in critical care settings, nephrology, pulmonology, and emergency medicine, where rapid and reliable assessment of CO₂ levels is essential for timely intervention. The assay supports comprehensive metabolic evaluation and aids in guiding therapeutic strategies for patients with renal, respiratory, or systemic disorders.
Key Features
- Quantitative measurement of total CO₂ in serum and plasma
- Sensitive indicator of acid–base balance and bicarbonate concentration
- Supports diagnosis and monitoring of metabolic and respiratory acidosis/alkalosis
- Enzymatic methodology ensures high accuracy, reproducibility, and reliability
- Compatible with Hitachi 917, Olympus AU600/400/640/2700, and CA 180/270/400 Furuno/Daytona analyzers
Benefits
The Biorex CO₂ Assay provides precise, reproducible, and clinically meaningful results, enabling healthcare providers to make informed decisions regarding patient care. Its broad applicability ensures utility across hospital laboratories, outpatient clinics, and research facilities. By delivering rapid and reliable data on acid–base status, this assay enhances the ability to diagnose, monitor, and manage metabolic and respiratory disorders effectively.
Integration into laboratory workflows is seamless due to its compatibility with multiple automated analyzers, ensuring consistent and accurate results. Routine use of the Biorex CO₂ Assay supports improved patient outcomes by providing critical information for monitoring systemic metabolic health and guiding treatment decisions.
Contact Us for more information.
